Ironwood Pharmaceuticals, A Buy At $12
May 24, 2013 8:34 PM | about stocks: IRWD May 2013. I recommend Ironwood ( IRWD ) a Buy at $12.00. The company's new drug is growing revenue and acceptance in the marketplace. Factors: 1) Good Management 2) Inside Ownership 3) Leader in Field 4) Favorable Risk/Reward 6) Competitive Edge 7) Strong Product Offering Disclosure: I am long IRWD . Stocks: IRWD